Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 5
2011 1
2014 1
2016 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
van der Horst G, Bos L, van der Mark M, Cheung H, Heckmann B, Clément-Lacroix P, Lorenzon G, Pelger RC, Bevers RF, van der Pluijm G. van der Horst G, et al. Among authors: lorenzon g. PLoS One. 2014 Sep 23;9(9):e108464. doi: 10.1371/journal.pone.0108464. eCollection 2014. PLoS One. 2014. PMID: 25247809 Free PMC article.
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.
Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Vitale F, Cristiano L, Martellucci S, Marampon F, Mattei V, Beirinckx F, Pujuguet P, Saniere L, Lorenzon G, van der Aar E, Festuccia C. Gravina GL, et al. Among authors: lorenzon g. Cancers (Basel). 2019 Mar 13;11(3):359. doi: 10.3390/cancers11030359. Cancers (Basel). 2019. PMID: 30871240 Free PMC article.
Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, Lorenzon G, Heckmann B, Feyen J, Pujuguet P, Blanque R, Clément-Lacroix P, van der Pluijm G. van der Horst G, et al. Among authors: lorenzon g. Neoplasia. 2011 Jun;13(6):516-25. doi: 10.1593/neo.11122. Neoplasia. 2011. PMID: 21677875 Free PMC article.
A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies.
Cirkel GA, Kerklaan BM, Vanhoutte F, Van der Aa A, Lorenzon G, Namour F, Pujuguet P, Darquenne S, de Vos FY, Snijders TJ, Voest EE, Schellens JH, Lolkema MP. Cirkel GA, et al. Among authors: lorenzon g. Invest New Drugs. 2016 Apr;34(2):184-92. doi: 10.1007/s10637-015-0320-9. Epub 2016 Jan 20. Invest New Drugs. 2016. PMID: 26792581 Free PMC article. Clinical Trial.
SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.
Wakata A, Matsuoka A, Yamakage K, Yoshida J, Kubo K, Kobayashi K, Senjyu N, Itoh S, Miyajima H, Hamada S, Nishida S, Araki H, Yamamura E, Matsui A, Thybaud V, Lorenzon G, Marzin D, Lorge E. Wakata A, et al. Among authors: lorenzon g. Mutat Res. 2006 Aug 4;607(1):88-124. doi: 10.1016/j.mrgentox.2006.04.003. Epub 2006 Jun 19. Mutat Res. 2006. PMID: 16782396